Empery Asset Management’s ProMIS Neurosciences PMN Stock Holding History

Empery Asset Management’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60,353	Closed	-$766K	–	36
2026 Q1	$766K	Buy	+60,353	New	+$900K	0.92%	14

Other funds holding PMN

Jupiter Topco New York $245B AUM

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Yu Fan $108M AUM 137.54% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Squadron Capital Management Westmont, Illinois $322M AUM

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Empery Asset Management's PMN Position: Q2 2026 in Review

Empery Asset Management sold out of ProMIS Neurosciences (PMN) in Q2 2026, closing a stake of 60,353 shares — an estimated $766K sold.

Empery Asset Management first reported a position in PMN in Q1 2026 and held it in 1 quarter. The position peaked at $766K in Q1 2026. 27 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

Empery Asset Management reported no remaining ProMIS Neurosciences position as of Q2 2026 after selling out during the quarter.
Empery Asset Management sold 60,353 ProMIS Neurosciences shares in Q2 2026, an estimated $766K.
Empery Asset Management first reported a position in ProMIS Neurosciences in Q1 2026 and held it in 1 quarter.
Empery Asset Management's ProMIS Neurosciences position peaked at $766K in Q1 2026.
27 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on Empery Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.